Bioanalytics for the development of biopharmaceuticals
Description
Development of bioanalytical methods for the characterization of novel glycoprotein-based pharmaceuticals regarding integrity, stability, charge profile, shares of monomers and multimers, monosaccharide shares of N-glycans, as well as the quantitative assessment of antigen binding with early developability of lead candidates.
Key data
Projectlead
Project status
completed, 01/2024 - 12/2025
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Third party